We aim to develop and investigate ways to improve the care provided to women with IBD who are planning pregnancy, pregnant, peripartum and post partum.

INTERESTED or HAVE QUESTIONS?  Wish to participate or volunteer?

If you are interested in participating in any of the studies, please email us at Vivian.Huang@sinaihealth.ca (Toronto) or Huangibdclinic@sinaihealth.ca or call (416)586-4800 ext 2475.


Clinical Management Studies


a) OMNI pilot (Optimizing Maternal and Neonatal Outcomes in IBD)

In this pilot study assess e-health and remote monitoring approach towards “tight control management” of IBD during pregnancy, we hope to show that close and frequent monitoring of objective disease markers (FCP fecal calprotectin, marker of intestinal inflammation) and optimization if needed of medical management of IBD, can improve maternal and neonatal outcomes.   This first pilot study will assess acceptability and feasibility of close and frequent monitoring of the clinical disease activity scores and FCP in pregnant patients who have IBD.  This study is being conducted out of Mount Sinai Hospital, Toronto. 





b) Counseling to Optimize Medication Adherence in Expectant Mothers with Inflammatory Bowel Disease (COACH-IBD) Study

In this randomized controlled trial of patient-centered counseling incorporating motivational interviewing and telemedicine-based follow-up by an IBD nurse, we hope to show that this additional counseling can improve medication adherence and pregnancy outcomes.  We also hope to validate the use of self-reported medication adherence during pregnancy in the IBD population.   This study is being conducted out of Mount Sinai Hospital, Toronto and University of Calgary, Calgary.